600329.SS · 达仁堂
China A-shares · RS rating 55 · As of 2026-10-14
| Price | 36.77 CNY |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 87 / 35 / 44 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 19 / 16 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -38.0% |
| Distance from 52-week high | +26.5% |
| Market cap (USD) | $4.1B |